科技翻译

朱月娥 李广践

目录

  • 1 导论
    • 1.1 开课问卷
    • 1.2 课程简介
    • 1.3 课程评价构成
    • 1.4 课程大纲与参考书目
    • 1.5 科技翻译的作用
    • 1.6 科技翻译译者的素养
    • 1.7 学生习作展示
  • 2 中国科技翻译简史
    • 2.1 中国翻译史
    • 2.2 中国科技翻译史
    • 2.3 重要科学翻译家
    • 2.4 主题悦读
    • 2.5 学生习作展示
  • 3 科技翻译标准与方法
    • 3.1 科技翻译的标准
    • 3.2 科技翻译的方法与技巧
      • 3.2.1 直译法&意译法&音译法
      • 3.2.2 增译法和减译法
      • 3.2.3 拆译法
    • 3.3 科技文本的文体特征
    • 3.4 主题悦读
  • 4 科技词汇-术语的翻译
    • 4.1 科技术语的命名原则
    • 4.2 术语的定义、翻译
      • 4.2.1 术语翻译的本质及基本特征
      • 4.2.2 术语翻译是国际化还是民族化
    • 4.3 术语库的建立
    • 4.4 主题悦读
  • 5 句子的翻译
    • 5.1 英语长句的特征与翻译
    • 5.2 汉语长句的特征与翻译
    • 5.3 科技翻译中的逻辑再现
    • 5.4 科技英语否定结构的翻译
    • 5.5 科技英语被动句的翻译
    • 5.6 简单句与复杂句的转换
  • 6 科技语篇特征与翻译
    • 6.1 农林业、生态
      • 6.1.1 林业语篇翻译
      • 6.1.2 林业语篇翻译2
    • 6.2 生命科学
    • 6.3 医学
    • 6.4 机电工程
    • 6.5 航天航空
    • 6.6 主题悦视
    • 6.7 学生译作欣赏
  • 7 科技翻译之美
    • 7.1 艺术与科技
    • 7.2 美的体现
    • 7.3 主题悦读
    • 7.4 学生习作展示
    • 7.5 素材
  • 8 科技翻译经典品鉴
    • 8.1 科技典藉译作欣赏
    • 8.2 科技影视作品欣赏
  • 9 翻译技术在科技翻译中的应用
    • 9.1 因特网的应用
    • 9.2 计算机辅助翻译
    • 9.3 Trados使用技巧
    • 9.4 字幕翻译的消音和配音
    • 9.5 主题悦读
  • 10 科技翻译实践-博物馆、科技馆实地考察
    • 10.1 博物馆、科技馆考察汇报PPT
      • 10.1.1 2019级科技馆实习汇报
    • 10.2 博物馆、科技馆实践反馈
    • 10.3 主题悦读
    • 10.4 翻译练笔
  • 11 节译与编译
    • 11.1 素材
    • 11.2 主题悦读
      • 11.2.1 主题悦读
      • 11.2.2 主题悦读
    • 11.3 编译
      • 11.3.1 主题悦读
      • 11.3.2 主题悦读
      • 11.3.3 主题悦读
      • 11.3.4 主题悦读
      • 11.3.5 主题悦读
    • 11.4 主题悦视
  • 12 科技论文写作与翻译
    • 12.1 如何查找文献
    • 12.2 怎样写出一篇好文章
    • 12.3 科技论文摘要写作与翻译
    • 12.4 科技论文写作
    • 12.5 专利翻译
  • 13 课程结语
    • 13.1 End-of-the-term survey
主题悦读

How useful are vaccine passports?

Identity schemes have a part to play in the return to life as normal, but only a modest one

The Economist Mar 13th 2021

The world has stumbled through the pandemic by nationalising risk. In heavily infected countries the state has shut citizens in their homes for weeks at a time, letting them out only for exercise and to buy food. As vaccination spreads, and hospitals are less likely to be overrun, governments must gradually move choice back to the individual, where it belongs. How?

Information is part of the answer. This week the Centres for Disease Control and Prevention issued the first guidance on what vaccinated people can do. More is needed. True, covid-19 is still poorly understood and the risk for individuals will depend on their own circumstances. Yet, as our covid-19 risk estimator in this issue explains, the data already cast some light on what puts you at risk if you are diagnosed with the disease. Age is closely tied to death, so do not visit your unvaccinated grandparents, however healthy they may be. Comorbidities can lead to a spell in hospital even for the young, so don’t imagine you are safe just because you’re under 35. More work like this will be needed for people to be able to make informed decisions about covid-19, just as they do in the rest of their lives. 

There is a role for vaccine passports, too. AmericaBritainand the European Union are all studying how they might be made to work. Angela Merkel, the German chancellor, has spoken up for them. Israel, where vaccination is advanced, already has such a system.

Vaccine passports have their uses, especially in international travel, but at home they are unlikely to be as helpful as their supporters imagine. To see why, consider two extremes. When nobody is vaccinated, passports obviously serve no purpose. Yet, outside a dictatorship, they are not terribly useful at the end, when everyone who wants a jab has had one. If vaccines are free and widely available, unvaccinated people are choosing to risk infection. Those who cannot be vaccinated face extra risks from covid-19, just as they do from other diseases. Passports are most useful in the period when large numbers of people who want to be inoculated risk being infected because vaccine is scarce. That is also when passports are most unfair.

For international travel this window could remain open for years. Countries with a large tourism industry can use passports to help protect their people from visitors bringing in disease. Even if global vaccine distribution raises ethical questions, the passport system itself presents none that are new, because it is already established for diseases like yellow fever. 

At home, however, the window may remain open for only a few months. Britain plans to have all adults vaccinated by the end of July. America will have enough doses to finish soon after. Even in Europe, where inoculation has been slow, a sweeping vaccine-passport system may not be worth the cost or the hassle.

Supporters argue that passports are an incentive for people to be vaccinated. If they are well-designed, they need not pose a threat to personal data; nor need they become a platform that the state later uses to intrude into citizens’ general health. However, the more heavily passports are used as an incentive, the more they are oppressive. If you need one simply to get on a bus or buy a loaf of bread, you lose your choice to be vaccinated. Most employers should have no use for them. Better to encourage people to get a jab.

That leaves two reasons for passports at home. One is to enforce vaccination when infected people could harm those who have had their jabs in hospitals and care homes, for example—rather as some countries already require proof that those working with vulnerable people have no criminal record. The other is as an insurance policy against the possibility that boosters are needed, to deal with variants, say. Countries have often looked for magic solutions to stop the pandemic. The only one that promises to succeed is not passports; it is vaccines.